PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0024115|lung disease |
| Sentences | 40 |
| PubMedID- 25006405 | Tada-phild (tadalafil for pulmonary hypertension associated with chronic obstructive lung disease) is the first sufficiently powered randomized clinical trial testing the effect of pde-5i on key clinical and drug safety outcome measures in patients with at least moderate ph due to copd. |
| PubMedID- 21719760 | Rationale: senescence of pulmonary artery smooth muscle cells (pa-smcs) caused by telomere shortening or oxidative stress may contribute to pulmonary hypertension associated with chronic lung diseases. |
| PubMedID- 24671311 | Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis. |
| PubMedID- 25046428 | pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis. |
| PubMedID- 22034605 | [30] patients with pulmonary hypertension associated with underlying lung diseases such as chronic obstructive pulmonary disease (copd), pulmonary fibrosis, and sarcoidosis, also are at increased risk of mortality,[31–38] and those with combined emphysema, interstitial lung disease and pulmonary hypertension have a particularly high mortality risk, with only a 60% one-year survival. |
| PubMedID- 22054725 | Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: case report and review of the literature. |
| PubMedID- 20522579 | pulmonary hypertension (ph) associated with parenchymal lung diseases is one of the most common forms of ph. |
| PubMedID- 21538327 | Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. |
| PubMedID- 25813769 | Background: pulmonary hypertension associated with lung disease (phld) has been shown to be a predictor of disease severity and survival in patients awaiting lung transplantation. |
| PubMedID- 24697923 | Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with pde-5 inhibitors. |
| PubMedID- 22415303 | Little is known regarding the cellular and molecular mechanisms that lead to pulmonary hypertension in patients with interstitial lung disease, and effective treatment options are lacking. |
| PubMedID- 26029570 | We also present a review of the literature on treatment of pulmonary hypertension in patients with chronic lung disease. |
| PubMedID- 20819757 | Chronic hypoxia is the major mechanism implicated for the development of pulmonary hypertension in patients with lung diseases. |
| PubMedID- 26283756 | Methods: one hundred thirty-four patients with clinically diagnosed interstitial lung diseases complicated by pulmonary hypertension underwent transthoracic lung sonography and doppler echocardiography for assessment of the presence of b-lines, the distance between them, and the pulmonary artery (pa) systolic pressure. |
| PubMedID- 23797369 | We tested whether sscpah or systemic sclerosis-related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than ipah and leads to worse rv contractile function. |
| PubMedID- 21474572 | Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 26453478 | Purpose: recent imaging studies demonstrated the usefulness of quantitative computed tomographic (ct) analysis assessing pulmonary hypertension (ph) in patients with chronic obstructive lung disease (copd-ph). |
| PubMedID- 21536179 | pulmonary hypertension associated with chronic infiltrative lung diseases can be detected by echocardiography and must be confirmed by right-sided heart catheterization, especially to rule out post-capillary pulmonary hypertension frequent in this context. |
| PubMedID- 25076998 | Chronic lung diseases are common causes of pulmonary hypertension. |
| PubMedID- 26115628 | The treatment of choice for patients who are hypoxemic and have pulmonary hypertension associated with chronic lung disease is long-term oxygen therapy. |
| PubMedID- 26293503 | Severe pulmonary hypertension in lung disease: phenotypes and response to treatment. |
| PubMedID- 23837116 | The evaluation of rv function is important for assessing prognosis in severe pulmonary hypertension associated with chronic obstructive lung disease. |
| PubMedID- 22884387 | Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. |
| PubMedID- 23271856 | We report a nigerian sickle cell patient who presented with computed tomography proven interstitial lung disease complicated by pulmonary hypertension and cor pulmonale. |
| PubMedID- 22958673 | Patients with lung diseases associated with pre-existing pulmonary hypertension (mean pap > 25 mm hg at rest) are advised against high altitude travel. |
| PubMedID- 21693294 | Effect of pulmonary hypertension in patients with end-stage lung disease on posttransplantation outcomes. |
| PubMedID- 24027689 | In recent years, the use of ino for “off-label” indications, such as for rescue treatment of preterm infants with severe respiratory failure, babies with severe chronic lung disease complicated by pulmonary hypertension and for prevention of bronchopulmonary dysplasia (bpd) has increased greatly. |
| PubMedID- 25613108 | Role of bnp and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model. |
| PubMedID- 25183617 | We report the case of a 75-years-old man who diagnosed with severe pulmonary hypertension, associated with interstitial lung disease characterized by a rapid and fatal outcome. |
| PubMedID- 25378843 | [25] the prevalence of isolated pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease in systemic sclerosis were similar and ranged between 18 and 22% in various studies. |
| PubMedID- 26361668 | pulmonary hypertension (ph) associated with lung diseases not only is an index of poor outcome but also is an indication for bilateral procedure. |
| PubMedID- 20920139 | The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 21941650 | Signs of chronic heart disease, pulmonary fibrosis, or emphysema suggest that patients may have pulmonary venous hypertension or pulmonary hypertension associated with chronic lung disease rather than pah. |
| PubMedID- 21613438 | Purpose: to study the reliability of pulmonary vascular measurements based on computed tomography (ct) in the prediction of pulmonary hypertension (ph) in patients with advanced interstitial lung disease (ild) compared with those without ild. |
| PubMedID- 23920210 | Background: pulmonary hypertension is frequently associated with parenchymal lung disease. |
| PubMedID- 20092992 | pulmonary hypertension in lung diseases: survey of beliefs and practice patterns. |
| PubMedID- 23354416 | pulmonary hypertension is often associated with inflammatory lung diseases, for example chronic obstructive pulmonary disease, or autoimmune diseases. |
| PubMedID- 22936711 | We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate cyclase stimulator, in patients with pulmonary hypertension associated with interstitial lung disease (ph-ild). |
| PubMedID- 21266048 | Background: chronic alveolar hypoxia, due to residence at high altitude or chronic obstructive lung diseases, leads to pulmonary hypertension, which may be further complicated by right heart failure, increasing morbidity and mortality. |
| PubMedID- 23841910 | Severe obstructive lung disease with pulmonary hypertension may be a contraindication for lung flooding. |
Page: 1